• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Microfluidics is a technology that allows researchers to precisely manipulate and control tiny amounts of fluids within networks of channels typically smaller than a human hair. The approach is now achieving the extreme miniaturization necessary to truly enter the ‘lab-on-a-chip’ era, with profound implications for biological research and human health.
As 2025 comes peeking around the corner, we invite you to look back with us at some of the most exciting science topics we covered this year. From advances in women’s health, organoids, and organ-on-a-chip models to the challenges of data science and innovations in animal science and sustainable biotech; let us walk you through the Benelux life sciences landscape of 2024 as we reflect on the vast amount of knowledge and know-how characteristic to this region.
Every start-up team ponders the all-important question: how to convince investors to fund their idea? Currently, the fundraising landscape is particularly challenging for most early-stage biotech ventures. A fortunate few are raising exorbitant rounds, allowing them to advance their products through preclinical development, but many others are struggling to find the funding they require. In this article, we share our investor perspective on what can help companies to stand out from the crowd, given recent advancements in drug development.
A world where we can 3D bioprint organs on demand is creeping ever closer to clinical reality, thanks to Belgian efforts to standardize the biomaterials necessary. Achieving this will have profound consequences for organ transplants, disease modeling, tissue engineering, personalized medicine, and drug discovery. But bioprinting success depends on multidisciplinary collaborations between material scientists, hardware manufacturers, clinicians, and other partners. Recently, these collaborations have reached the stratosphere, with a project to study cardiovascular aging with a heart-on-a-chip… in space!
Cervical cancer is largely curable if detected early enough and yet it remains a leading cause of death in women globally. Why? Although researchers recently made the biggest improvement in cervical cancer treatment in more than 20 years, cutting the risk of death by over 40%, effective and inclusive screening remains crucial for early detection and treatment. However, recent research from Belgium suggests that certain populations of vulnerable women or those with a migration background are falling through the cervical cancer screening cracks.
Data science is vastly changing the way we do research. Veterinary research is, however, still lagging behind its human counterpart. Why is this the case and can we learn from human health data to close this gap?
ATMPs (advanced therapy medicinal products) are expected to reach a global value of 80 billion euro in 2032. While it can be tempting to try to go it alone, the fastest and most intelligent way to advance is by advancing together. The event, Advanced Therapies in Belgium, presents such an occasion, offering a space for innovative ideas and featuring speakers from the forefront of the Belgian and international ATMP innovation.
There has been an unprecedented surge of investments in sustainable agriculture and food technologies in the last decade, but that trend now appears to have reversed into a free fall in funding. This pattern of promise-to-disillusionment perfectly matches the hype cycle previously demonstrated by breakthrough technologies in other sectors. Can we forge a path forward for sustainable agrifood start-ups?
Our current food system is responsible for around a third of global greenhouse gas emissions, extensive deforestation, unsustainable water usage, and an unprecedented loss of biodiversity. Currently, the processes used to produce our food represent an obstacle to limiting average global temperature increases to the levels set out in the Paris Agreement. But are these damaging effects of our current food production landscape an unavoidable cost of feeding humanity or can smart investments in sustainable agritech be part of the solution?
In a hospital, numerous single-use masks, gloves, syringes, and more are thrown away every day to safeguard patients. However, this linear supply chain leaves a large footprint and can have negative effects on our environment and public health. It seems that the road to achieving sustainable healthcare is not straightforward, but circular.
  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Microfluidics is a technology that allows researchers to precisely manipulate and control tiny amounts of fluids within networks of channels typically smaller than a human hair. The approach is now achieving the extreme miniaturization necessary to truly enter the ‘lab-on-a-chip’ era, with profound implications for biological research and human health.
As 2025 comes peeking around the corner, we invite you to look back with us at some of the most exciting science topics we covered this year. From advances in women’s health, organoids, and organ-on-a-chip models to the challenges of data science and innovations in animal science and sustainable biotech; let us walk you through the Benelux life sciences landscape of 2024 as we reflect on the vast amount of knowledge and know-how characteristic to this region.
Every start-up team ponders the all-important question: how to convince investors to fund their idea? Currently, the fundraising landscape is particularly challenging for most early-stage biotech ventures. A fortunate few are raising exorbitant rounds, allowing them to advance their products through preclinical development, but many others are struggling to find the funding they require. In this article, we share our investor perspective on what can help companies to stand out from the crowd, given recent advancements in drug development.
A world where we can 3D bioprint organs on demand is creeping ever closer to clinical reality, thanks to Belgian efforts to standardize the biomaterials necessary. Achieving this will have profound consequences for organ transplants, disease modeling, tissue engineering, personalized medicine, and drug discovery. But bioprinting success depends on multidisciplinary collaborations between material scientists, hardware manufacturers, clinicians, and other partners. Recently, these collaborations have reached the stratosphere, with a project to study cardiovascular aging with a heart-on-a-chip… in space!
Cervical cancer is largely curable if detected early enough and yet it remains a leading cause of death in women globally. Why? Although researchers recently made the biggest improvement in cervical cancer treatment in more than 20 years, cutting the risk of death by over 40%, effective and inclusive screening remains crucial for early detection and treatment. However, recent research from Belgium suggests that certain populations of vulnerable women or those with a migration background are falling through the cervical cancer screening cracks.
Data science is vastly changing the way we do research. Veterinary research is, however, still lagging behind its human counterpart. Why is this the case and can we learn from human health data to close this gap?
ATMPs (advanced therapy medicinal products) are expected to reach a global value of 80 billion euro in 2032. While it can be tempting to try to go it alone, the fastest and most intelligent way to advance is by advancing together. The event, Advanced Therapies in Belgium, presents such an occasion, offering a space for innovative ideas and featuring speakers from the forefront of the Belgian and international ATMP innovation.
There has been an unprecedented surge of investments in sustainable agriculture and food technologies in the last decade, but that trend now appears to have reversed into a free fall in funding. This pattern of promise-to-disillusionment perfectly matches the hype cycle previously demonstrated by breakthrough technologies in other sectors. Can we forge a path forward for sustainable agrifood start-ups?
Our current food system is responsible for around a third of global greenhouse gas emissions, extensive deforestation, unsustainable water usage, and an unprecedented loss of biodiversity. Currently, the processes used to produce our food represent an obstacle to limiting average global temperature increases to the levels set out in the Paris Agreement. But are these damaging effects of our current food production landscape an unavoidable cost of feeding humanity or can smart investments in sustainable agritech be part of the solution?
In a hospital, numerous single-use masks, gloves, syringes, and more are thrown away every day to safeguard patients. However, this linear supply chain leaves a large footprint and can have negative effects on our environment and public health. It seems that the road to achieving sustainable healthcare is not straightforward, but circular.